From a molecular clinical viewpoint, Relafen 750 (Naproxen) exhibits unique behaviors. It operates primarily as a cyclooxygenase agent, preferentially suppressing cyclooxygenase-2 (COX-2), an protein https://bookmark-dofollow.com/story28037078/relafen-750-a-biochemical-pharmacy-perspective